Melissa M Phillips
Melissa M Phillips
1Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
2Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew’s Hospital, West Smithfield, London, EC1A 7BE UK
1,2,#,
Iuliia Pavlyk
Iuliia Pavlyk
1Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
1,#,
Michael Allen
Michael Allen
3Center for Tumor Microenvironment, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
3,
Essam Ghazaly
Essam Ghazaly
4Centre for Haemato-Oncology, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
5Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK
4,5,
Rosalind Cutts
Rosalind Cutts
6Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK
6,
Josephine Carpentier
Josephine Carpentier
1Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
1,
Joe Scott Berry
Joe Scott Berry
1Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
1,
Callum Nattress
Callum Nattress
1Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
1,
Shenghui Feng
Shenghui Feng
1Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
1,
Gunnel Hallden
Gunnel Hallden
1Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
1,
Claude Chelala
Claude Chelala
1Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
1,
John Bomalaski
John Bomalaski
7Polaris Pharmaceuticals, Inc., San Diego, CA 92121 USA
7,
Jeremy Steele
Jeremy Steele
2Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew’s Hospital, West Smithfield, London, EC1A 7BE UK
2,
Michael Sheaff
Michael Sheaff
8Department of Histopathology, Barts Health NHS Trust, Royal London Hospital, London, E1 1BB UK
8,
Frances Balkwill
Frances Balkwill
3Center for Tumor Microenvironment, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
3,
Peter W Szlosarek
Peter W Szlosarek
1Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
2Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew’s Hospital, West Smithfield, London, EC1A 7BE UK
1,2,✉
1Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
2Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew’s Hospital, West Smithfield, London, EC1A 7BE UK
3Center for Tumor Microenvironment, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
4Centre for Haemato-Oncology, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ UK
5Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK
6Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK
7Polaris Pharmaceuticals, Inc., San Diego, CA 92121 USA
8Department of Histopathology, Barts Health NHS Trust, Royal London Hospital, London, E1 1BB UK
© The Author(s) 2023
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.